IMMCO Diagnostics Overview

  • Founded
  • 1971
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 72
Employees
  • Latest Deal Type
  • Debt - PPP
  • Latest Deal Amount
  • $1.04M
Latest Deal Amount

IMMCO Diagnostics General Information

Description

Provider of diagnostic products and services. The company offers autoimmune diagnostic medical devices, including assays for collagen vascular, gastrointestinal, liver, vesiculo-bullous, endocrine, neuroimmunological, and cardiovascular disorders, as well as for hearing loss. The company provides various diagnostic services, such as serology, genetics, and pathology in dermatology/dermatopathology, endocrinology, gastroenterology/hepatology, ocular pathology, oral pathology, otolaryngology, neurology, and rheumatology fields.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Acquirer
Primary Office
  • 60 Pineview Drive
  • Amherst, NY 14228
  • United States
+1 (716) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IMMCO Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Debt - PPP 15-Apr-2020 $1.04M Completed Generating Revenue
2. Merger/Acquisition 26-Jul-2013 000.00 00.00 000.00 Completed Generating Revenue
1. Early Stage VC (Series A1) 14-Dec-2007 $6.9M $6.9M 0000 Completed Generating Revenue
To view IMMCO Diagnostics’s complete valuation and funding history, request access »

IMMCO Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 00,000 00.000000 00 0000.00 0000.00 00 0000.00 0.000
Series A1 00,000 00.000000 00 0000.0 0000.00 00 0000.0 000
To view IMMCO Diagnostics’s complete cap table history, request access »

IMMCO Diagnostics Patents

IMMCO Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019232867-B2 Improved anti-nuclear antibody detection and diagnostics for systemic and non-systemic autoimmune disorders Active 24-Mar-2014 00000000000
EP-3122766-A1 Improved anti-nuclear antibody detection and diagnostics for systemic and non-systemic autoimmune disorders Granted 24-Mar-2014 00000000000
AU-2021203868-A1 Improved anti-nuclear antibody detection and diagnostics for systemic and non-systemic autoimmune disorders Pending 24-Mar-2014 00000000000
AU-2015236327-A1 Improved anti-nuclear antibody detection and diagnostics for systemic and non-systemic autoimmune disorders Granted 24-Mar-2014 00000000000
CA-2942347-A1 Improved anti-nuclear antibody detection and diagnostics for systemic and non-systemic autoimmune disorders Pending 24-Mar-2014 G01N33/6854

IMMCO Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IMMCO Diagnostics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Summit Partners PE/Buyout Minority 000 0000 000000 0
To view IMMCO Diagnostics’s complete investors history, request access »